Masimo recently experienced a cyberattack that has affected manufacturing capacity at some of its facilities, the company said in a May 6 filing with the SEC. Four notes: 1. On April 27, the company said it identified “unauthorized activity” within…
Supply Chain
In its latest drug expenditure forecast, the American Society of Health-System Pharmacists identified potential pharmaceutical tariffs as a policy threat that could drive up hospital drug costs and worsen supply chain instability. The American Hospital Association, in a May 6…
GE Healthcare introduced new technology at the Estro 2025 Congress that is designed to use AI to make planning radiation for cancer treatment faster and more accurate. The model, MR Contour DL, uses deep learning to segment 37 organs in…
U.S. medical device companies are starting to feel the financial pressure from the current imposed tariffs, with Baxter International and GE Healthcare reporting millions in projected costs. Here are four things to know:
The Senate rejected a resolution that sought to end President Donald Trump’s baseline tariff and additional tariffs on imported goods, The New York Times reported April 30. Here are four things to know:
Advertisement
Abbott has issued a recall for select HeartMate mobile power units used with its HeartMate3 and HeartMate III left-ventricular assist systems due to risk of sudden power loss that could lead to serious injury or death. The recall affects power…
Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the second half of the year stemming from…
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know:
DHL Express announced a temporary suspension of business-to-consumer shipments valued over $800 to private individuals in the U.S., effective April 21. The move is in response to the new U.S. Customs and Border Protection regulations that reduce the threshold for…
The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, both SOLO and non-SOLO versions, manufactured by BD and its subsidiary Bard…